Aimable Nahimana

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Venues

Molecules (Basel, Switzerland)

Cancers

Cell death & disease

International journal of molecular sciences

University Hospital of Lausanne (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University Hospital of Lausanne Dec 11 2017

Switzerland

PHD :: Central Laboratory of Hematology

Publications

Paulina Biniecka, Saki Matsumoto, Axel Belotti, Jessie Joussot, Jian Fei Bai, Somi Reddy Majjigapu, Paul Thoueille, Dany Spaggiari, Vincent Desfontaine, Francesco Piacente, Santina Bruzzone, Michele Cea, Laurent A Decosterd, Pierre Vogel, Alessio Nencioni, Michel A Duchosal, Aimable Nahimana
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies. Molecules (Basel, Switzerland) 28 (4) (2023)
Paulina Biniecka, Saki Matsumoto, Axel Belotti, Jessie Joussot, Jian Fei Bai, Somi Reddy Majjigapu, Paul Thoueille, Dany Spaggiari, Vincent Desfontaine, Francesco Piacente, Santina Bruzzone, Michele Cea, Laurent A Decosterd, Pierre Vogel, Alessio Nencioni, Michel A Duchosal, Aimable Nahimana
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies. Molecules (Basel, Switzerland) 28 (4) (2023)
Saki Matsumoto, Paulina Biniecka, Axel Bellotti, Michel A Duchosal, Aimable Nahimana
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia. Cancers 15 (3) (2023)
Paulina Biniecka, Saki Matsumoto, Axel Belotti, Jessie Joussot, Jian Fei Bai, Somi Reddy Majjigapu, Paul Thoueille, Dany Spaggiari, Vincent Desfontaine, Francesco Piacente, Santina Bruzzone, Michele Cea, Laurent A Decosterd, Pierre Vogel, Alessio Nencioni, Michel A Duchosal, Aimable Nahimana
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies. Molecules (Basel, Switzerland) 28 (4) (2023)
Paulina Biniecka, Saki Matsumoto, Axel Belotti, Jessie Joussot, Jian Fei Bai, Somi Reddy Majjigapu, Paul Thoueille, Dany Spaggiari, Vincent Desfontaine, Francesco Piacente, Santina Bruzzone, Michele Cea, Laurent A Decosterd, Pierre Vogel, Alessio Nencioni, Michel A Duchosal, Aimable Nahimana
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological Malignancies. Molecules (Basel, Switzerland) 28 (4) (2023)
Saki Matsumoto, Paulina Biniecka, Axel Bellotti, Michel A Duchosal, Aimable Nahimana
Nicotinaldehyde, a Novel Precursor of NAD Biosynthesis, Abrogates the Anti-Cancer Activity of an NAD-Lowering Agent in Leukemia. Cancers 15 (3) (2023)
Oussama ElMokh, Saki Matsumoto, Paulina Biniecka, Axel Bellotti, Karin Schaeuble, Francesco Piacente, Hector Gallart-Ayala, Julijana Ivanisevic, Ivan Stamenkovic, Alessio Nencioni, Aimable Nahimana, Michel A Duchosal
Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemia. Cell death & disease 13 (4) (2022)
Maxime Pellegrin, Karima Bouzourène, Jean-François Aubert, Aimable Nahimana, Michel A Duchosal, Lucia Mazzolai
Activation of Bone Marrow-Derived Cells Angiotensin (Ang) II Type 1 Receptor by Ang II Promotes Atherosclerotic Plaque Vulnerability. International journal of molecular sciences 19 (9) (2018)

Aimable Nahimana.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Aimable Nahimana